News
08-02-2023, 08:28 PM
In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies.
More... (https://www.news-medical.net/news/20230802/Novel-strategy-can-potentially-control-MAPK4-promoted-growth-in-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20230802/Novel-strategy-can-potentially-control-MAPK4-promoted-growth-in-triple-negative-breast-cancer.aspx)